AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
77 hedge funds and large institutions have $135M invested in AVEO Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Holders
77
Holding in Top 10
2
Calls
$3.7M
Puts
$291K
Top Buyers
| 1 | +$6.1M | |
| 2 | +$3.03M | |
| 3 | +$1.74M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.6M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$1.42M |
Top Sellers
| 1 | -$5.45M | |
| 2 | -$4.05M | |
| 3 | -$1.71M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.65M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$259K |